Peer-influenced content. Sources you trust. No registration required. This is HCN.
ReachMD
“The idea of preserving and reducing thrombosis without increasing bleeding is very, very exciting.” — Roxana Mehran, MD, SCAI 2025
Cardiology March 25th 2026
Epoch Health
“Use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.” — FDA Class II Recall Definition
Cardiology March 10th 2026
Annals of Internal Medicine
The primary study outcome was a composite of serious bleeding events leading to hospitalization. Secondary study outcomes included composites of stroke or systemic embolism.
MDLinx
The updated “Ritter Rules” reinforce that early recognition and multidisciplinary collaboration are critical to surviving aortic dissection.
Cardiology Advisor
Continued collaboration across disciplines, enhanced focus on standardization, and investments in emerging technologies are imperative for bridging the gaps and driving innovation.
Cardiology February 10th 2026
Cath Lab Digest
Given that the patient lived 80 years with this congenital condition without right atrial or right ventricular enlargement or significant pulmonary hypertension, the decision was made to manage medically.